Managing Chemotherapy-Related Cardiotoxicity in Survivors of Childhood Cancers

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Cardiotoxicity 75%
• Cardiovascular Disease 50%
• Hypertension 50%
• Heart Arrhythmia 50%
• Anthracycline 50%
• Cardiomyopathy 50%
• Childhood Cancer 50%
• Chemotherapy 50%
• Atherosclerosis 25%
• Morbidity 25%
• Drug 25%
• Biological Marker 25%
• Protein Tyrosine Kinase Inhibitor 25%
• Vasculotropin Receptor 25%
• Razoxane 25%
• Mortality 25%

Biochemistry, Genetics and Molecular Biology

• Anthracycline 50%
• Childhood 50%
• Lifespan 25%
• Vascular Endothelial Growth Factor 25%
• Morbidity 25%
• Mortality 25%
• Dexrazoxane 25%